The spread and uptake pattern of intracerebrally administered oligonucleotides in nerve and glial cell populations of the rat brain. 1998

W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.

The fate of 15-mer phosphorothioate-modified antisense oligonucleotides to c-fos was followed after their microinjection into rat brain. Using radiolabeled oligonucleotides, it was demonstrated that the bulk of the material stays in the injected region but that a minor part is transported with the projection pathways to regions far away from the site of injection. Using tetramethylrhodamine-isothiocyanate (TRITC) labeling as well as fluorescein isothiocyanate (FITC) labeling, it was found that the oligonucleotides were taken up by a great number of cells within 30 minutes after the injection. A diffuse cytoplasmic staining and also nuclear staining were observed in these cells, which could be identified exclusively as neurons by double labeling for the neuron-specific protein NeuN. At later times (6, 24, and 48 hours), the appearance of the oligonucleotides changed gradually to a punctate cytoplasmic staining, which by electron microscopic analysis was shown to be caused by the presence of the oligonucleotides in intracellular vesicles. The pattern of intracellular fluorescence was changed when the oligonucleotides were injected together with the cationic lipid 1,2-bis(oleoyloxy)-3-(trimethylammonio)propane (DOTAP). A small number of astrocytes and microglial cells were found to be labeled by the oligonucleotides, but only at later times after the injection and exclusively in a punctate cytoplasmic manner. Thus, the uptake of oligonucleotides in the nerve and glial cell populations of the brain might involve different mechanisms, the one in the neurons appearing to be very rapid and potent.

UI MeSH Term Description Entries
D008297 Male Males
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001253 Astrocytes A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. Astroglia,Astroglia Cells,Astroglial Cells,Astrocyte,Astroglia Cell,Astroglial Cell,Astroglias,Cell, Astroglia,Cell, Astroglial
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D013873 Thionucleotides Nucleotides in which the base moiety is substituted with one or more sulfur atoms.
D016376 Oligonucleotides, Antisense Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. Anti-Sense Oligonucleotide,Antisense Oligonucleotide,Antisense Oligonucleotides,Anti-Sense Oligonucleotides,Anti Sense Oligonucleotide,Anti Sense Oligonucleotides,Oligonucleotide, Anti-Sense,Oligonucleotide, Antisense,Oligonucleotides, Anti-Sense

Related Publications

W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
October 1995, Regulatory peptides,
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
August 1977, Life sciences,
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
January 2000, Experimental neurology,
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
August 2000, The European journal of neuroscience,
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
January 1983, Cold Spring Harbor symposia on quantitative biology,
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
March 1989, Science (New York, N.Y.),
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
January 1989, Neurochemistry international,
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
January 2012, Methods in molecular biology (Clifton, N.J.),
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
January 1987, Progress in brain research,
W Sommer, and X Cui, and B Erdmann, and L Wiklund, and G Bricca, and M Heilig, and K Fuxe
January 1962, Journal of neurochemistry,
Copied contents to your clipboard!